Hedge Fund - Aisling Capital
Esperion Therapeutics Inc. (ESPR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2017 - Q4 (2017-12-31) | $0 | 0% | 0 | $53.84 |
| 2 | 2017 - Q3 (2017-09-30) | $41,957,000 | 6.89% | 837,125 | $48.22 |
| 3 | 2017 - Q2 (2017-06-30) | $38,742,000 | 6.63% | 837,125 | $36.77 |
| 4 | 2017 - Q1 (2017-03-31) | $29,559,000 | 5.38% | 837,125 | $22.90 |
| 5 | 2016 - Q4 (2016-12-31) | $20,497,000 | 4.76% | 1,637,125 | $11.91 |
| 6 | 2016 - Q3 (2016-09-30) | $22,674,000 | 4.67% | 1,637,125 | $11.33 |
| 7 | 2016 - Q2 (2016-06-30) | $16,175,000 | 3.81% | 1,637,125 | $16.57 |
| 8 | 2016 - Q1 (2016-03-31) | $27,684,000 | 5.54% | 1,637,125 | $16.09 |
| 9 | 2015 - Q4 (2015-12-31) | $36,442,000 | 6.28% | 1,637,125 | $25.23 |
| 10 | 2015 - Q3 (2015-09-30) | $38,620,000 | 6.78% | 1,637,125 | $62.76 |
| 11 | 2015 - Q2 (2015-06-30) | $133,851,000 | 19.93% | 1,637,125 | $97.89 |
| 12 | 2015 - Q1 (2015-03-31) | $190,255,000 | 24.89% | 2,054,594 | $64.53 |
| 13 | 2014 - Q4 (2014-12-31) | $83,088,000 | 12.59% | 2,054,594 | $30.61 |
| 14 | 2014 - Q3 (2014-09-30) | $50,260,000 | 9.74% | 2,054,594 | $15.89 |
| 15 | 2014 - Q2 (2014-06-30) | $32,540,000 | 9.42% | 2,054,594 | $14.45 |
The displayed share prices are average quarterly stock market prices.